FDA INDICATION: Control and prevention of bleeding episodes and perioperative management in adults and children (0–16 years) with hemophilia A. Routine prophylaxis to reduce the frequency of bleeding episodes and the risk of joint damage in children with hemophilia A with no preexisting joint damage.
DISTRIBUTOR: CSL Behring
ASSAY SIZE (IU): 250, 500, 1000, 1500, 2000, 3000
DILUENT SIZE: 2.5 mL (250 IU, 500 IU, 1000 IU), 5.0 mL (2000 IU, 3000 IU)
MIXING DEVICE: Mix2Vial®
ROOM TEMPERATURE STORAGE: 12 months
HALF-LIFE: Approximately 13 hours
OTHER WEBSITES: cslbehring.com, helixatefs.com